You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3501 to 3525 of about 5971
Next 25
10/28/2008
Mechanism in cells that generate malignant brain tumors may offer target for gene therapy
Fundraiser: Fine Wines for the Holidays!
10/21/2008
Recycling Program to Raise Funds for Brain Tumor Research
The second annual FRED COHEN MEMORIAL SYMPOSIUM "Managing Life with a Brain Tumor: A Practical Approach for Patients & Families"
10/19/2008
Temozolomide for high grade glioma.
High-grade glioma before and after treatment with radiation and Avastin: Initial observations
HR 7153: The National Childhood Brain Tumor Prevention Network Act
IBTA E-NEWSLETTER 15 October 2008
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
Local tennis: Swingtime announces Super Bowl tickets drawing
10/17/2008
Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
The chances of developing a malignant tumour are “significantly increased” for people who use a mobile for ten years.
Experience with irinotecan for the treatment of malignant glioma
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases
Monmouth Medical Center art exhibit features original artwork created by kids and teens affected by a loved one’s brain tumor
10/09/2008
Free tickets to NY Islanders and Virtualtrials.com is moving!
10/08/2008
Target Acquired: It may become possible to vaccinate against brain tumours
10/06/2008
Urbana quilt project raises money for brain cancer research
UCSF surgeon changes study of brain tumors
10/04/2008
Proton Radiation Appears to Lower Risk for Secondary Cancers
Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.
Prospective phase II trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (LRF) hyperthermia.
A phase II trial with cetuximab, bevacizumab, and irinotecan for patients with primary glioblastomas and progression after radiation therapy and temozolamide.
Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)
Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.